• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4640408)   Today's Articles (208)   Subscriber (50364)
For: Kaplan S, Garvin D, Gilhooly P, Koppel M, Labasky R, Milsten R, Reddy P, Rosenberg S, Sussman D, White C, Lee M, Pappas F, Waldstreicher J. Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride. The Pless Study Group. Urology 2000;56:610-6. [PMID: 11018616 DOI: 10.1016/s0090-4295(00)00724-x] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Number Cited by Other Article(s)
1
Di X, Jin X, Ai J, Xiang L, Gao X, Xiao K, Li H, Luo D, Wang K. YAP/Smad3 promotes pathological extracellular matrix microenviroment-induced bladder smooth muscle proliferation in bladder fibrosis progression. MedComm (Beijing) 2022;3:e169. [PMID: 36176734 PMCID: PMC9477793 DOI: 10.1002/mco2.169] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2022] [Revised: 07/17/2022] [Accepted: 07/22/2022] [Indexed: 11/06/2022]  Open
2
Ryan PC, Ryan ÉJ, Keenan RA, Haroon UM, Broe MP, Forde JC, Galvin D, Lennon GM, Murphy M, Quinlan DM, Mulvin DW. Admission of patients with acute urinary retention leads to a definitive management decision. Ir J Med Sci 2020;189:999-1003. [PMID: 31858451 DOI: 10.1007/s11845-019-02164-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2019] [Accepted: 12/05/2019] [Indexed: 11/26/2022]
3
Lee YJ, Lee JW, Park J, Seo SI, Chung JI, Yoo TK, Son H. Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea. Investig Clin Urol 2016;57:424-430. [PMID: 27847916 PMCID: PMC5109794 DOI: 10.4111/icu.2016.57.6.424] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2016] [Accepted: 09/13/2016] [Indexed: 11/27/2022]  Open
4
Toren P, Margel D, Kulkarni G, Finelli A, Zlotta A, Fleshner N. Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study. BMJ 2013;346:f2109. [PMID: 23587564 PMCID: PMC3626257 DOI: 10.1136/bmj.f2109] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
5
Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasia. Urology 2013;81:1177-82. [PMID: 23522295 DOI: 10.1016/j.urology.2013.01.051] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2012] [Revised: 01/10/2013] [Accepted: 01/11/2013] [Indexed: 11/20/2022]
6
Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: who are the high-risk patients and what are the best treatment options? Curr Opin Urol 2011;21:42-8. [DOI: 10.1097/mou.0b013e32834100b3] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
7
Tacklind J, Fink HA, MacDonald R, Rutks I, Wilt TJ. Finasteride for benign prostatic hyperplasia. Cochrane Database Syst Rev 2010;2010:CD006015. [PMID: 20927745 PMCID: PMC8908761 DOI: 10.1002/14651858.cd006015.pub3] [Citation(s) in RCA: 51] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
8
Martín-Merino E, García-Rodríguez LA, Massó-González EL, Roehrborn CG. Do Oral Antimuscarinic Drugs Carry an Increased Risk of Acute Urinary Retention? J Urol 2009;182:1442-8. [DOI: 10.1016/j.juro.2009.06.051] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2009] [Indexed: 11/30/2022]
9
Kramer BS, Hagerty KL, Justman S, Somerfield MR, Albertsen PC, Blot WJ, Carter HB, Costantino JP, Epstein JI, Godley PA, Harris RP, Wilt TJ, Wittes J, Zon R, Schellhammer P. Use of 5α-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. J Urol 2009;181:1642-57. [DOI: 10.1016/j.juro.2009.01.071] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
10
Kramer BS, Hagerty KL, Justman S, Somerfield MR, Albertsen PC, Blot WJ, Ballentine Carter H, Costantino JP, Epstein JI, Godley PA, Harris RP, Wilt TJ, Wittes J, Zon R, Schellhammer P. Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. J Clin Oncol 2009;27:1502-16. [PMID: 19252137 DOI: 10.1200/jco.2008.16.9599] [Citation(s) in RCA: 76] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
11
Scofield S, Kaplan SA. Voiding dysfunction in men: pathophysiology and risk factors. Int J Impot Res 2008;20 Suppl 3:S2-10. [DOI: 10.1038/ijir.2008.54] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
12
The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia. Int J Impot Res 2008;20 Suppl 3:S19-26. [PMID: 19002120 DOI: 10.1038/ijir.2008.53] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
13
Tareen B, Godoy G, Laze J, Lepor H. Does Open Radical Retropubic Prostatectomy Decrease the Risk of Acute Urinary Retention? Urology 2008;72:821-4. [DOI: 10.1016/j.urology.2008.04.027] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2008] [Revised: 04/04/2008] [Accepted: 04/15/2008] [Indexed: 11/28/2022]
14
Kaplan SA, Wein AJ, Staskin DR, Roehrborn CG, Steers WD. Urinary Retention and Post-Void Residual Urine in Men: Separating Truth From Tradition. J Urol 2008;180:47-54. [DOI: 10.1016/j.juro.2008.03.027] [Citation(s) in RCA: 77] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2007] [Indexed: 10/22/2022]
15
Patel AK, Chapple CR. Medical management of lower urinary tract symptoms in men: current treatment and future approaches. ACTA ACUST UNITED AC 2008;5:211-9. [DOI: 10.1038/ncpuro1060] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2007] [Accepted: 01/14/2008] [Indexed: 01/10/2023]
16
Tiwari A. Advances in the development of hormonal modulators for the treatment of benign prostatic hyperplasia. Expert Opin Investig Drugs 2007;16:1425-39. [PMID: 17714028 DOI: 10.1517/13543784.16.9.1425] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
17
Marks LS, Roehrborn CG, Andriole GL. Prevention of benign prostatic hyperplasia disease. J Urol 2006;176:1299-306. [PMID: 16952616 DOI: 10.1016/j.juro.2006.06.022] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2005] [Indexed: 11/25/2022]
18
Patel AK, Chapple CR. Benign prostatic hyperplasia: treatment in primary care. BMJ 2006;333:535-9. [PMID: 16960209 PMCID: PMC1562476 DOI: 10.1136/bmj.38946.616551.be1] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
19
Marks LS. Use of 5α-reductase inhibitors to prevent benign prostatic hyperplasia disease. Curr Urol Rep 2006;7:293-303. [PMID: 16930501 DOI: 10.1007/s11934-996-0009-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
20
Harkaway RC, Issa MM. Medical and minimally invasive therapies for the treatment of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 2006;9:204-14. [PMID: 16755276 DOI: 10.1038/sj.pcan.4500869] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
21
Roehrborn CG. Definition of at-risk patients: baseline variables. BJU Int 2006;97 Suppl 2:7-11; discussion 21-2. [PMID: 16507046 DOI: 10.1111/j.1464-410x.2006.06098.x] [Citation(s) in RCA: 82] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
22
Mochtar CA, Kiemeney LALM, van Riemsdijk MM, Laguna MP, Debruyne FMJ, de la Rosette JJMCH. Post-Void Residual Urine Volume is Not a Good Predictor of the Need for Invasive Therapy Among Patients With Benign Prostatic Hyperplasia. J Urol 2006;175:213-6. [PMID: 16406914 DOI: 10.1016/s0022-5347(05)00038-8] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2004] [Revised: 04/08/2005] [Indexed: 11/29/2022]
23
Mochtar CA, Kiemeney LALM, Laguna MP, van Riemsdijk MM, Barnett GS, Debruyne FMJ, de la Rosette JJMCH. Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting. Urology 2005;65:300-5. [PMID: 15708042 DOI: 10.1016/j.urology.2004.09.030] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2004] [Accepted: 09/16/2004] [Indexed: 01/23/2023]
24
Berges R, Höfner K. Medikamentöse BPS-Therapie. Urologe A 2005;44:505-12. [PMID: 15841355 DOI: 10.1007/s00120-005-0798-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
25
Kim ED. The use of baseline clinical measures to predict those at risk for progression of benign prostatic hyperplasia. Curr Urol Rep 2004;5:267-73. [PMID: 15260926 DOI: 10.1007/s11934-004-0049-z] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
26
Cullen J, Schwartz MD, Lawrence WF, Selby JV, Mandelblatt JS. Short-term impact of cancer prevention and screening activities on quality of life. J Clin Oncol 2004;22:943-52. [PMID: 14990651 DOI: 10.1200/jco.2004.05.191] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
27
Roehrborn CG. The potential of serum prostate-specific antigen as a predictor of clinical response in patients with lower urinary tract symptoms and benign prostatic hyperplasia. BJU Int 2004;93 Suppl 1:21-6. [PMID: 15009082 DOI: 10.1111/j.1464-410x.2003.04636.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
28
Emberton M, Andriole GL, de la Rosette J, Djavan B, Hoefner K, Vela Navarrete R, Nordling J, Roehrborn C, Schulman C, Teillac P, Tubaro A, Nickel JC. Benign prostatic hyperplasia: a progressive disease of aging men. Urology 2003;61:267-73. [PMID: 12597928 DOI: 10.1016/s0090-4295(02)02371-3] [Citation(s) in RCA: 151] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
29
Edwards JE, Moore RA. Finasteride in the treatment of clinical benign prostatic hyperplasia: a systematic review of randomised trials. BMC Urol 2002;2:14. [PMID: 12477383 PMCID: PMC140032 DOI: 10.1186/1471-2490-2-14] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2002] [Accepted: 12/12/2002] [Indexed: 12/21/2022]  Open
30
Barry MJ, Roehrborn CG. Benign prostatic hyperplasia. BMJ (CLINICAL RESEARCH ED.) 2001;323:1042-6. [PMID: 11691764 PMCID: PMC1121545 DOI: 10.1136/bmj.323.7320.1042] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
31
Kaplan SA, Holtgrewe HL, Bruskewitz R, Saltzman B, Mobley D, Narayan P, Lund RH, Weiner S, Wells G, Cook TJ, Meehan A, Waldstreicher J. Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia. Urology 2001;57:1073-7. [PMID: 11377309 DOI: 10.1016/s0090-4295(01)00985-2] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA